XOMA 2017 Cowen Health Care Conference Presentation

XOMA Corporation presented at the Cowen & Company 37th Annual Health Care Conference in March 2017. The company discussed its antibody discovery platform, clinical pipeline including XOMA 358 for hyperinsulinemia, XOMA 129 for acute severe hypoglycemia, and XOMA 213 for prolactinemia, along with monetization opportunities and value creation strategy.